SHARE PRICE > View All Stock Detailed Share Information Latest News Interim Management Statement Q1 2022 of Molecular Partners: Cash Runway into 2026 and Portfolio Progress Highlight Strategic Momentum Molecular Partners to Participate in Upcoming Healthcare Investor Conferences Molecular Partners CEO, Patrick Amstutz, Elected President of the Swiss Biotech Association > View All News All News Upcoming Events More events are coming soon. > View All Events All Events Latest Presentation May 16, 2022 MP Corporate Presentation April 25, 2022 Kempen Conference Presentation March 16, 2022 Publication of full year results 2021 > View All Presentations All Presentations Latest Financial Documents May 12, 2022 Q1 2022 Financial Statement March 15, 2022 Annual Report FY2021 October 28, 2021 Q3 2021 Financial Statement > View All Reports All Annual Report Seth Lewis, SVP Investor Relations, Communications and Strategy Contact Seth STAY INFORMED Subscribe to email alerts of your choosing SUBSCRIBE Institutional investors: REQUEST 1-1 / CALL powered by schedulR
Interim Management Statement Q1 2022 of Molecular Partners: Cash Runway into 2026 and Portfolio Progress Highlight Strategic Momentum
